Peter Reiss is Emeritus Professor of Medicine at the Amsterdam UMC, University of Amsterdam in Amsterdam, the Netherlands. He maintains a guest appointment in the Department of Global Health and the division of Infectious Diseases and continues his research through the Amsterdam Institute for Global Health and Development.
Professor Reiss served as the Director of the Netherlands HIV Monitoring Foundation until April 2021, and in this position for many years served on the Steering Committees of the D:A:D study, the Antiretroviral Therapy Cohort Collaboration, the HIV Causal Collaboration, and the International Collaboration on Hepatitis C Elimination in HIV-Coinfection. Prof. Reiss remains a member of the Scientific Advisory Board of the Pierre Louis Institute of Epidemiology and Public Health in Paris, France, the US NIH/NIAID HIV Vaccine Data and Safety Monitoring Board, and is a programme committee member of various conferences, including CROI, the European AIDS Conference-EACS and HIV Glasgow.
He has previously served on the Scientific Advisory Boards of the Swiss HIV Cohort Study, the Agence Nationale de Recherches sur de Sida et les hepatitis virales (ANRS), the EuroSida Study, and as one of the four rotating scientific coordinators of EuroCoord. He served as President of the European Aids Clinical Society (EACS) (2008-2012), as the European and Central Asia regional representative on the Governing Council of the International Aids Society (IAS) (2006 – 2014), and as co-chair of the 22nd International AIDS Conference (AIDS 2018).
Professor Reiss is clinical HIV section editor for Antiviral Therapy and editorial board member of a number of other journals. A significant part of his research focuses on the long-term complications of HIV and HIV treatment, and more particularly in relation to ageing.
